HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lili Liu Selected Research

human MGr1-antigen

6/2014MGr1-Ag/37LRP induces cell adhesion-mediated drug resistance through FAK/PI3K and MAPK pathway in gastric cancer.
6/2013MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.
9/2007Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lili Liu Research Topics

Disease

81Neoplasms (Cancer)
07/2022 - 06/2002
29Neoplasm Metastasis (Metastasis)
01/2022 - 02/2010
21Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2007
19Lung Neoplasms (Lung Cancer)
07/2022 - 12/2002
13Hypoxia (Hypoxemia)
10/2019 - 01/2008
10Infections
07/2022 - 06/2012
10Inflammation (Inflammations)
01/2022 - 04/2016
9Carcinoma (Carcinomatosis)
05/2022 - 01/2003
8Carcinogenesis
01/2020 - 12/2002
7Adenocarcinoma of Lung
03/2022 - 09/2011
7Chronic Renal Insufficiency
10/2021 - 05/2017
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 09/2010
6Fibrosis (Cirrhosis)
08/2021 - 08/2011
6Lymphatic Metastasis
01/2021 - 01/2014
6Breast Neoplasms (Breast Cancer)
01/2020 - 01/2012
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2018 - 09/2010
5COVID-19
07/2022 - 01/2020
5Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 12/2018
5Colonic Neoplasms (Colon Cancer)
10/2021 - 06/2002
5Chronic Obstructive Pulmonary Disease (COPD)
10/2021 - 07/2016
5Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 04/2014
4Sepsis (Septicemia)
09/2022 - 01/2020
4Cognitive Dysfunction
01/2022 - 07/2016
4Esophageal Squamous Cell Carcinoma
12/2021 - 05/2018
4Pain (Aches)
09/2021 - 04/2016
4Type 2 Diabetes Mellitus (MODY)
08/2021 - 02/2012
4Glioma (Gliomas)
08/2021 - 09/2008
4Proteinuria
08/2021 - 01/2020
4Hepatocellular Carcinoma (Hepatoma)
07/2021 - 01/2012
4Hypertension (High Blood Pressure)
01/2021 - 01/2012
4Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 12/2014
4Necrosis
01/2020 - 10/2009
3Respiratory Tract Infections (Respiratory Tract Infection)
07/2022 - 01/2014
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2020
3Adenocarcinoma
01/2022 - 01/2019
3Kidney Diseases (Kidney Disease)
08/2021 - 01/2020
3Rupture
05/2021 - 01/2019
3Stroke (Strokes)
04/2021 - 01/2018
3Allergic Rhinitis
01/2021 - 05/2020
3Asthma (Bronchial Asthma)
01/2021 - 08/2015
3Dyslipidemias (Dyslipidemia)
01/2021 - 04/2016
3Triple Negative Breast Neoplasms
01/2021 - 01/2015
3Rheumatoid Arthritis
01/2021 - 09/2018
3Dermatitis
01/2020 - 01/2013
3Acquired Immunodeficiency Syndrome (AIDS)
06/2018 - 02/2013
3Melanoma (Melanoma, Malignant)
01/2018 - 11/2005
3Pathologic Processes
06/2017 - 12/2014
3Endometrial Neoplasms (Endometrial Cancer)
10/2015 - 09/2013

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
05/2022 - 05/2007
18Pharmaceutical PreparationsIBA
12/2021 - 06/2002
15Small Interfering RNA (siRNA)IBA
01/2021 - 09/2007
14Long Noncoding RNAIBA
05/2022 - 12/2014
12Messenger RNA (mRNA)IBA
01/2021 - 04/2009
11Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2013
10MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
10Biological ProductsIBA
01/2022 - 04/2010
8Glucose (Dextrose)FDA LinkGeneric
08/2021 - 05/2008
8DNA (Deoxyribonucleic Acid)IBA
06/2021 - 09/2002
7CytokinesIBA
12/2021 - 08/2002
6LuciferasesIBA
05/2022 - 04/2009
6EnzymesIBA
03/2022 - 12/2012
5Cisplatin (Platino)FDA LinkGeneric
07/2022 - 09/2011
5RNA (Ribonucleic Acid)IBA
05/2022 - 07/2010
5CateninsIBA
01/2022 - 01/2017
5AntigensIBA
01/2021 - 01/2012
5methoxyamineIBA
11/2015 - 10/2003
5Temozolomide (Temodar)FDA LinkGeneric
01/2015 - 10/2003
5Carmustine (FIVB)FDA Link
05/2012 - 10/2003
5O(6)-benzylguanineIBA
05/2012 - 09/2002
4VimentinIBA
07/2022 - 01/2012
4AntibodiesIBA
01/2022 - 01/2012
4Therapeutic UsesIBA
01/2021 - 04/2015
4LipidsIBA
12/2020 - 05/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2015
4Transcription Factors (Transcription Factor)IBA
03/2016 - 02/2012
4Alkylating AgentsIBA
01/2015 - 06/2004
4Factor VIII (Coagulation Factor VIII)IBA
12/2014 - 02/2012
3Indicators and Reagents (Reagents)IBA
09/2022 - 01/2021
3Cadherins (E-Cadherin)IBA
07/2022 - 06/2013
3A-Form DNA (A-DNA)IBA
01/2022 - 01/2020
3Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2017
3C-Reactive ProteinIBA
08/2021 - 01/2016
3Insulin (Novolin)FDA Link
04/2021 - 01/2019
3Estrogen ReceptorsIBA
01/2021 - 05/2019
3SmokeIBA
12/2020 - 09/2010
3CreatinineIBA
12/2020 - 01/2020
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2020 - 09/2013
3Adenosine Triphosphate (ATP)IBA
01/2020 - 11/2015
3Trichloroethylene (Trichloroethene)IBA
01/2020 - 01/2013
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2017 - 08/2010
3LeptinIBA
01/2017 - 09/2013
3LigandsIBA
08/2016 - 01/2012
3Laminin (Merosin)IBA
07/2014 - 08/2010
3human MGr1-antigenIBA
06/2014 - 09/2007
3DNA alkyltransferaseIBA
05/2012 - 09/2002

Therapy/Procedure

33Therapeutics
01/2022 - 06/2002
16Drug Therapy (Chemotherapy)
07/2022 - 06/2002
4Aftercare (After-Treatment)
06/2021 - 06/2002
4Radiotherapy
01/2020 - 09/2011
3Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 01/2021